224 related articles for article (PubMed ID: 18363519)
21. Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.
Perera LP; Waldmann TA; Mosca JD; Baldwin N; Berzofsky JA; Oh S
J Virol; 2007 Aug; 81(16):8774-83. PubMed ID: 17553867
[TBL] [Abstract][Full Text] [Related]
22. Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel.
Faix DJ; Gordon DM; Perry LN; Raymond-Loher I; Tati N; Lin G; DiPietro G; Selmani A; Decker MD
Vaccine; 2020 Oct; 38(46):7323-7330. PubMed ID: 32967791
[TBL] [Abstract][Full Text] [Related]
23. New generation smallpox vaccines: a review of preclinical and clinical data.
Artenstein AW
Rev Med Virol; 2008; 18(4):217-31. PubMed ID: 18283712
[TBL] [Abstract][Full Text] [Related]
24. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
[TBL] [Abstract][Full Text] [Related]
25. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
[TBL] [Abstract][Full Text] [Related]
26. Genomic sequence and analysis of a vaccinia virus isolate from a patient with a smallpox vaccine-related complication.
Li G; Chen N; Feng Z; Buller RM; Osborne J; Harms T; Damon I; Upton C; Esteban DJ
Virol J; 2006 Oct; 3():88. PubMed ID: 17062162
[TBL] [Abstract][Full Text] [Related]
27. Adverse events following smallpox vaccination with ACAM2000 in a military population.
Beachkofsky TM; Carrizales SC; Bidinger JJ; Hrncir DE; Whittemore DE; Hivnor CM
Arch Dermatol; 2010 Jun; 146(6):656-61. PubMed ID: 20566929
[TBL] [Abstract][Full Text] [Related]
28. Prospective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic review.
Elizaga ML; Vasan S; Marovich MA; Sato AH; Lawrence DN; Chaitman BR; Frey SE; Keefer MC;
PLoS One; 2013; 8(1):e54407. PubMed ID: 23349878
[TBL] [Abstract][Full Text] [Related]
29. Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus.
Parker S; Crump R; Foster S; Hartzler H; Hembrador E; Lanier ER; Painter G; Schriewer J; Trost LC; Buller RM
Antiviral Res; 2014 Nov; 111():42-52. PubMed ID: 25128688
[TBL] [Abstract][Full Text] [Related]
30. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
[TBL] [Abstract][Full Text] [Related]
31. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine.
Weltzin R; Liu J; Pugachev KV; Myers GA; Coughlin B; Blum PS; Nichols R; Johnson C; Cruz J; Kennedy JS; Ennis FA; Monath TP
Nat Med; 2003 Sep; 9(9):1125-30. PubMed ID: 12925845
[TBL] [Abstract][Full Text] [Related]
32. Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox.
Wei H; Huang D; Fortman J; Wang R; Shao L; Chen ZW
J Virol; 2009 Jan; 83(2):1115-25. PubMed ID: 19004937
[TBL] [Abstract][Full Text] [Related]
33. Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities.
Merkel TJ; Perera PY; Kelly VK; Verma A; Llewellyn ZN; Waldmann TA; Mosca JD; Perera LP
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18091-6. PubMed ID: 20921397
[TBL] [Abstract][Full Text] [Related]
34. A mouse-based assay for the pre-clinical neurovirulence assessment of vaccinia virus-based smallpox vaccines.
Zhang CX; Sauder C; Malik T; Rubin SA
Biologicals; 2010 Mar; 38(2):278-83. PubMed ID: 19896867
[TBL] [Abstract][Full Text] [Related]
35. A Case Series of Smallpox Vaccination-Associated Myopericarditis: Effects on Safety and Readiness of the Active Duty Soldier.
Sarkisian SA; Hand G; Rivera VM; Smith M; Miller JA
Mil Med; 2019 Jan; 184(1-2):e280-e283. PubMed ID: 29947793
[TBL] [Abstract][Full Text] [Related]
36. Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial.
Greenberg RN; Kennedy JS; Clanton DJ; Plummer EA; Hague L; Cruz J; Ennis FA; Blackwelder WC; Hopkins RJ
Lancet; 2005 Jan 29-Feb 4; 365(9457):398-409. PubMed ID: 15680454
[TBL] [Abstract][Full Text] [Related]
37. LC16m8: an attenuated smallpox vaccine.
Kenner J; Cameron F; Empig C; Jobes DV; Gurwith M
Vaccine; 2006 Nov; 24(47-48):7009-22. PubMed ID: 17052815
[TBL] [Abstract][Full Text] [Related]
38. Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.
Parrino J; McCurdy LH; Larkin BD; Gordon IJ; Rucker SE; Enama ME; Koup RA; Roederer M; Bailer RT; Moodie Z; Gu L; Yan L; Graham BS;
Vaccine; 2007 Feb; 25(8):1513-25. PubMed ID: 17126963
[TBL] [Abstract][Full Text] [Related]
39. Clinical guidance for smallpox vaccine use in a postevent vaccination program.
Petersen BW; Damon IK; Pertowski CA; Meaney-Delman D; Guarnizo JT; Beigi RH; Edwards KM; Fisher MC; Frey SE; Lynfield R; Willoughby RE
MMWR Recomm Rep; 2015 Feb; 64(RR-02):1-26. PubMed ID: 25695372
[TBL] [Abstract][Full Text] [Related]
40. Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAs.
Hermanson G; Chun S; Felgner J; Tan X; Pablo J; Nakajima-Sasaki R; Molina DM; Felgner PL; Liang X; Davies DH
Vaccine; 2012 Jan; 30(3):614-25. PubMed ID: 22100890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
